BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25050860)

  • 1. Accurate quantitation of MHC-bound peptides by application of isotopically labeled peptide MHC complexes.
    Hassan C; Kester MG; Oudgenoeg G; de Ru AH; Janssen GM; Drijfhout JW; Spaapen RM; Jiménez CR; Heemskerk MH; Falkenburg JH; van Veelen PA
    J Proteomics; 2014 Sep; 109():240-4. PubMed ID: 25050860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct quantitation of MHC-bound peptide epitopes by selected reaction monitoring.
    Tan CT; Croft NP; Dudek NL; Williamson NA; Purcell AW
    Proteomics; 2011 Jun; 11(11):2336-40. PubMed ID: 21598389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.
    Cohen CJ; Denkberg G; Lev A; Epel M; Reiter Y
    J Mol Recognit; 2003; 16(5):324-32. PubMed ID: 14523945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability.
    van der Burg SH; Visseren MJ; Brandt RM; Kast WM; Melief CJ
    J Immunol; 1996 May; 156(9):3308-14. PubMed ID: 8617954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
    Zügel U; Schoel B; Kaufmann SH
    J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular architecture of the MHC I peptide-loading complex: one tapasin molecule is essential and sufficient for antigen processing.
    Hulpke S; Baldauf C; Tampé R
    FASEB J; 2012 Dec; 26(12):5071-80. PubMed ID: 22923333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy.
    Dutoit V; Herold-Mende C; Hilf N; Schoor O; Beckhove P; Bucher J; Dorsch K; Flohr S; Fritsche J; Lewandrowski P; Lohr J; Rammensee HG; Stevanovic S; Trautwein C; Vass V; Walter S; Walker PR; Weinschenk T; Singh-Jasuja H; Dietrich PY
    Brain; 2012 Apr; 135(Pt 4):1042-54. PubMed ID: 22418738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioorthogonal cleavage and exchange of major histocompatibility complex ligands by employing azobenzene-containing peptides.
    Choo JA; Thong SY; Yap J; van Esch WJ; Raida M; Meijers R; Lescar J; Verhelst SH; Grotenbreg GM
    Angew Chem Int Ed Engl; 2014 Dec; 53(49):13390-4. PubMed ID: 25348595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural variants of the immunodominant HLA A11-restricted CTL epitope of the EBV nuclear antigen-4 are nonimmunogenic due to intracellular dissociation from MHC class I:peptide complexes.
    Levitsky V; Zhang QJ; Levitskaya J; Kurilla MG; Masucci MG
    J Immunol; 1997 Dec; 159(11):5383-90. PubMed ID: 9548478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generating data for databases--the peptide repertoire of HLA molecules.
    Stevanović S; Lemmel C; Häntschel M; Eberle U
    Novartis Found Symp; 2003; 254():143-55; discussion 155-64, 216-22, 250-2. PubMed ID: 14712936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a fluorescence polarization-based competitive peptide-binding assay for HLA-A*0201--a new tool for epitope discovery.
    Buchli R; VanGundy RS; Hickman-Miller HD; Giberson CF; Bardet W; Hildebrand WH
    Biochemistry; 2005 Sep; 44(37):12491-507. PubMed ID: 16156661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ever-growing peptide knowledge promotes the improvement of HLA class I peptide-binding prediction.
    Wang S; Wu Y
    Immunol Lett; 2013; 154(1-2):49-53. PubMed ID: 23994431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A naturally processed peptide presented by HLA-A*0201 is expressed at low abundance and recognized by an alloreactive CD8+ cytotoxic T cell with apparent high affinity.
    Wang W; Gulden PH; Pierce RA; Shabanowitz J; Man ST; Hunt DF; Engelhard VH
    J Immunol; 1997 Jun; 158(12):5797-804. PubMed ID: 9190931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of mass spectrometry-based proteomics to immunology.
    Hillen N; Stevanovic S
    Expert Rev Proteomics; 2006 Dec; 3(6):653-64. PubMed ID: 17181480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stepwise identification of HLA-A*0201-restricted CD8+ T-cell epitope peptides from herpes simplex virus type 1 genome boosted by a StepRank scheme.
    Bi J; Song R; Yang H; Li B; Fan J; Liu Z; Long C
    Biopolymers; 2011; 96(3):328-39. PubMed ID: 21072852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential presentation of tumor antigen-derived epitopes by MHC-class I and antigen-positive tumor cells.
    Held G; Neumann F; Sturm C; Kaestner L; Dauth N; de Bruijn DR; Renner C; Lipp P; Pfreundschuh M
    Int J Cancer; 2008 Oct; 123(8):1841-7. PubMed ID: 18688854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the affinity of epitope-peptides with class I MHC molecule HLA-A*0201: an application of amino acid-based peptide prediction.
    Du QS; Wei YT; Pang ZW; Chou KC; Huang RB
    Protein Eng Des Sel; 2007 Sep; 20(9):417-23. PubMed ID: 17681974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolute quantitation of protein posttranslational modification isoform.
    Yang Z; Li N
    Methods Mol Biol; 2015; 1306():105-19. PubMed ID: 25930697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A structural basis for antigen presentation by the MHC class Ib molecule, Qa-1b.
    Zeng L; Sullivan LC; Vivian JP; Walpole NG; Harpur CM; Rossjohn J; Clements CS; Brooks AG
    J Immunol; 2012 Jan; 188(1):302-10. PubMed ID: 22131332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.